Insulin Detemir

Drug Usage Statistics, United States, 2005 - 2015

Number of Prescriptions Over Time (2005 - 2015)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 684 -
2007 463  221
2008 253  210
2009 227  26
2010 225  2
Year Rank Change
2011 191  34
2012 168  23
2013 162  6
2014 145  17
2015 107  38

Patient Out-Of-Pocket Cost Over Time (2005 - 2015)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2015)
Insulin Glargine 22,223,562
Insulin Aspart 9,391,154
Insulin Detemir (this drug) 6,619,638
Insulin Lispro 6,303,715

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Levemir
  • Levemir Flexpen
  • Levemir Flextouch
  • Levemir Innolet
  • Levemir Penfill
Generic Drug Synonyms and Salts
  • Insulin Detemir Recombinant
  • Insulin Detemir

FDA Approval Information

Established Pharmacologic Class (EPC): Insulin Analog
Initial FDA approval date: 6/16/2005
First FDA applicant: Rx
First dosage form: Injectable (subcutaneous)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2005-2015. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 18.0. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

©2018 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top